ANBIPING

anbiping-logo

Anbiping focuses on the research and development, production and service of pathological diagnosis products.

#Financial #More

ANBIPING

Industry:
Biopharma Health Care Health Diagnostics Medical

Founded:
2005-01-01

Status:
Active

Contact:
020-32299997

Email Addresses:
[email protected]


Investments List

Date Company Article Money raised
2022-07-15 Gaugene Anbiping investment in Series B - Gaugene 100 M CNY
2022-05-19 Targene Medical Anbiping investment in Venture Round - Targene Medical N/A

More informations about "Anbiping"

Home-LBP SYSTEM

Home-Guangzhou Anbiping Medical Science and Technology Co. , Ltd. (stock code: 688393) focuses on tumor screening and diagnosis, independently developed a series of tumor …See details»

Anbiping - Crunchbase Investor Profile & Investments

Anbiping is a number of reagents and supporting devices have indeed been independently created by Anbiping, which focuses on tumour screening and correct diagnosis. Pathology is …See details»

广州安必平医药科技股份有限公司-肿瘤-筛查与诊断-LBP-PCR-IHC-…

广州安必平医药科技股份有限公司(股票代码:688393)专注于肿瘤筛查与诊断,自主研发了一系列肿瘤筛查及诊断试剂与配套设备,主要应用科室为病理科。目前已搭建液基细胞学(lbp) …See details»

Anbiping (Shaanxi) Pharmaceutical Technology Co., Ltd.

Feb 22, 2025 Explore Anbiping (Shaanxi) Pharmaceutical Technology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

安必平医学检验

广州安必平医学检验(简称“安必平医检”)是国内病理诊断领域首家上市企业——广州安必平医药科技股份有限公司(股票代码:688393)的控股子公司。安必平医检致力于让各级医疗机构 …See details»

About LBP-LBP SYSTEM - en.gzlbp.com

About LBP-Guangzhou Anbiping Medical Science and Technology Co. , Ltd. (stock code: 688393) focuses on tumor screening and diagnosis, independently developed a series of tumor …See details»

Anbiping - Funding, Financials, Valuation & Investors - Crunchbase

Anbiping is registered under the ticker SSE:688393 . Their stock opened with CN¥30.56 in its Aug 20, 2020 IPO. Anbiping is funded by 11 investors. ShenZhen GTJA Investment Group and …See details»

Anbiping - Investments, Portfolio & Company Exits - Crunchbase

Anbiping focuses on R&D, production, and service of pathological diagnostic products. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»

Guangzhou Lbp Medicine Science & Technology Co., Ltd. (China)

May 16, 2025 Anbiping (Guangzhou) Marketing Management Co., Ltd. 100%. Company Performance. Financial values in the chart are available after Guangzhou Lbp Medicine …See details»

Anbiping (Guangdong) Investment Co., Ltd. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Anbiping (Guangdong) Investment Co., Ltd. of Liannan County, Guangdong. Get the latest business …See details»

Hangzhou Anbiping Pharmaceutical Technology Co., Ltd.

Explore Hangzhou Anbiping Pharmaceutical Technology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

Guangzhou Anbiping Automated Testing Equipment Co., Ltd

Find company research, competitor information, contact details & financial data for Guangzhou Anbiping Automated Testing Equipment Co., Ltd of Guangzhou, Guangdong. Get the latest …See details»

Anbiping and Tencent launch cervical liquid-based cytology …

Aug 9, 2023 On November 25, witnessed by experts from the cytology group of the Pathology Branch of the Chinese Medical Association, Anbiping, Tencent AI Lab, and Tencent Miying …See details»

History-LBP SYSTEM

History-Guangzhou Anbiping Medical Science and Technology Co. , Ltd. (stock code: 688393) focuses on tumor screening and diagnosis, independently developed a series of tumor …See details»

Guangzhou Anbiping Medical Laboratory Co., Ltd.: Drug pipelines ...

Jul 2, 2023 Explore Guangzhou Anbiping Medical Laboratory Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

Anbiping - Updates, News, Events, Signals & Triggers - Crunchbase

Anbiping focuses on R&D, production, and service of pathological diagnostic products.See details»

Anbiping - Crunchbase

Anbiping focuses on R&D, production, and service of pathological diagnostic products.See details»

广州安必平医药科技股份有限公司

安必平成立于2005年,2020年8月20日在上交所科创板成功上市,是国内病理诊断领域首家上市公司。 公司专注于肿瘤筛查与精准诊断,自主研发了一系列试剂与配套设备,主要应用科室为 …See details»

安必平医检 - 安必平医学检验 - accupath.cn

广州安必平医学检验(简称“安必平医检”)是国内病理诊断领域首家上市企业——广州安必平医药科技股份有限公司(股票代码:688393)的控股子公司。安必平医检致力于让各级医疗机构 …See details»

Anbiping - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Anbiping focuses on R&D, production, and service of pathological diagnostic products.See details»